John Harold Leaman

Chief Financial Officer, Aevi Genomic Medicine, LLC.

Companies

Traws Pharma, Inc.Board member Oct 14, 2025 to now¹
Impel Neuropharma (United States)Chief Fin. & Business Officer Oct 21, 2021 to Feb 16, 2023²
Impel Neuropharma (United States)Chief financial officer Apr 22, 2021 to Jul 26, 2021³
Selecta Biosciences (United States)Chief financial officer Oct 26, 2017 to Jun 19, 2018⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Traws Pharma, Inc. TRAW4,058 shares⁵$1.5K at $0.38Dec 12, 2025
Impel Neuropharma (United States)6,944 shares⁶Dec 31, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 12, 2025Granted 4,058 shares of Traws Pharma, Inc.⁵
Dec 31, 2022Shares withheld for tax 3,627 shares at $3.75 of Impel Neuropharma (United States)⁶
Dec 31, 2022Exercised options 10,571 shares of Impel Neuropharma (United States)⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTraws Pharma, Inc., Board member
2
SEC EDGARImpel Neuropharma (United States), Chief Fin. & Business Officer
3
SEC EDGARImpel Neuropharma (United States), Chief financial officer
4
SEC EDGARSelecta Biosciences (United States), Chief financial officer
5
SEC EDGARTraws Pharma, Inc. shares after the filing of Dec 12, 2025
6
SEC EDGARImpel Neuropharma (United States) shares after the filing of Dec 31, 2022